These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4001727)

  • 21. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rubella in Poland in 2010].
    Karasek E; Paradowska-Stankiewicz I
    Przegl Epidemiol; 2012; 66(2):197-203. PubMed ID: 23101204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of congenital rubella and congenital varicella in Europe.
    Pandolfi E; Chiaradia G; Moncada M; Rava L; Tozzi AE
    Euro Surveill; 2009 Mar; 14(9):16-20. PubMed ID: 19317971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The opportunity and obligation to eliminate rubella from the United States.
    Orenstein WA; Bart KJ; Hinman AR; Preblud SR; Greaves WL; Doster SW; Stetler HC; Sirotkin B
    JAMA; 1984 Apr; 251(15):1988-94. PubMed ID: 6700103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit-cost aspects of rubella immunization.
    Schoenbaum SC
    Rev Infect Dis; 1985; 7 Suppl 1():S210-1. PubMed ID: 3923595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rubella. Surveillance to December 1990.
    Wkly Epidemiol Rec; 1991 Jul; 66(30):217-20. PubMed ID: 1911162
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review.
    Panagiotopoulos T; Antoniadou I; Valassi-Adam E
    BMJ; 1999 Dec; 319(7223):1462-7. PubMed ID: 10582926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing rubella vaccination policy in Nepal--results from rubella surveillance and seroprevalence and congenital rubella syndrome studies.
    Upreti SR; Thapa K; Pradhan YV; Shakya G; Sapkota YD; Anand A; Taylor T; Mach O; Reef S; Pattamadilok S; Liyanage J; O'Connor P; Sedai T; Bhandary SR; Partridge J; Schluter W
    J Infect Dis; 2011 Jul; 204 Suppl 1():S433-8. PubMed ID: 21666196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of congenital rubella and results of rubella vaccination in Australia.
    Menser MA; Hudson JR; Murphy AM; Upfold LJ
    Rev Infect Dis; 1985; 7 Suppl 1():S37-41. PubMed ID: 3890106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy.
    Enders G
    Rev Infect Dis; 1985; 7 Suppl 1():S103-7. PubMed ID: 4001718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Last cases of rubella and congenital rubella syndrome in Spain, 1997-2016: The success of a vaccination program.
    Seppälä EM; López-Perea N; Torres de Mier MV; Echevarría JE; Fernández-García A; Masa-Calles J
    Vaccine; 2019 Jan; 37(1):169-175. PubMed ID: 30454948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008.
    Castillo-Solórzano C; Reef SE; Morice A; Vascones N; Chevez AE; Castalia-Soares R; Torres C; Vizzotti C; Ruiz Matus C
    J Infect Dis; 2011 Sep; 204 Suppl 2():S713-7. PubMed ID: 21954271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
    Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP
    J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of congenital rubella syndrome in Japan, 1978-2002: effect of revision of the immunization law.
    Katow S
    Vaccine; 2004 Sep; 22(29-30):4084-91. PubMed ID: 15364460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up study of unknowingly pregnant women vaccinated against rubella in Brazil, 2001-2002.
    Soares RC; Siqueira MM; Toscano CM; Maia Mde L; Flannery B; Sato HK; Will RM; Rodrigues RC; Oliveira IC; Barbosa TC; Sá GR; Rego MF; Curti SP; Lemos XR; Morhdieck R; Stürmer D; Oliveira MJ; Barbosa da Silva Junior J; Castillo-Solórzano C; Camacho LA; Luna E
    J Infect Dis; 2011 Sep; 204 Suppl 2():S729-36. PubMed ID: 21954274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further efforts in the achievement of congenital rubella syndrome/rubella elimination.
    Cozza V; Martinelli D; Cappelli MG; Tafuri S; Fortunato F; Prato R
    Hum Vaccin Immunother; 2015; 11(1):220-4. PubMed ID: 25483539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.